HEOR Consulting

RWE Solutions · HEOR

HEOR Consulting: Health Economics and Outcomes Research

14 to 15 October 2026Hampton Inn by Hilton, Boston Seaport, USA

Health economics and outcomes research (HEOR) turns real-world evidence into the value story that payers, HTA bodies and health systems need in order to say yes.

Meet the HEOR consultancies, and the teams that commission them, at RWE Connect 2026 in Boston.

Put Your Company in Front of 150+ RWE Buyers
Request the sponsorship prospectus. We reply within one business day.

    No public pricing. Enquiry-led, no obligation.

    150+Attendees
    60%Director / VP and Above
    40+Speakers
    200+Meetings Facilitated

    Capabilities

    What HEOR Consulting Delivers

    HEOR consultancies build the economic and outcomes evidence that turns a therapy into a fundable one.

    Cost-Effectiveness Analysis
    Cost-utility and cost-effectiveness models, expressed as cost per QALY and ICERs.
    Budget Impact Models
    The affordability case for payers, systems and formularies.
    Burden of Illness
    Quantifying the clinical and economic burden of a condition.
    Value Dossiers
    AMCP and global value dossiers for payer and HTA submissions.
    Evidence Synthesis
    Systematic literature reviews, network meta-analysis and indirect comparisons.
    Patient-Reported Outcomes
    PRO and COA strategy, from instrument selection to analysis.

    How it works

    The HEOR Evidence Journey

    From a payer question to a reimbursement decision, HEOR connects the dots.

    Step 1
    Research QuestionThe decision the evidence must support.
    Step 2
    Evidence & DataReal-world data, trials and literature.
    Step 3
    Economic ModelCost-effectiveness and budget impact.
    Step 4
    Value StoryA clear, defensible value narrative.
    Step 5
    AccessHTA submission and reimbursement.

    Why now

    Why HEOR Matters Now

    Economic evidence has moved from nice-to-have to non-negotiable.

    Payer & HTA Scrutiny
    Payers and HTA bodies demand robust economic evidence before they pay.
    Value-Based Care
    Reimbursement increasingly ties to demonstrated outcomes and value.
    Constrained Budgets
    Finite budgets mean every therapy must prove its worth.

    The concepts

    Key HEOR Concepts Explained

    A handful of concepts underpin almost every HEOR analysis. Here is the plain-English version.

    Cost-Effectiveness (ICER)
    The incremental cost per unit of health gained, expressed as the ICER.
    QALY
    A quality-adjusted life year, combining length and quality of life.
    Budget Impact
    The affordability of a therapy for a payer’s whole population.
    Time Horizon
    The period over which costs and outcomes are counted.
    Discounting
    Adjusting future costs and benefits to their present value.
    Willingness to Pay
    The threshold a payer will pay per unit of health gained.

    In practice

    HEOR in Practice

    A simplified example shows how a cost-effectiveness analysis comes together. It is illustrative, not a specific study.

    Illustrative example
    QuestionIs a new therapy cost-effective versus standard care?
    ModelA cost-utility model run over a lifetime horizon.
    InputsReal-world effectiveness, costs and quality-of-life utilities.
    OutputAn ICER expressed as cost per QALY gained.
    DecisionCompared against the payer’s willingness-to-pay threshold.

    Turning real-world data into a defensible value story is exactly what the HEOR teams at RWE Connect 2026 do.

    Clearing it up

    HEOR vs Market Access

    The two are often confused. HEOR builds the evidence; market access uses it.

    HEOR

    • Generates the economic evidence
    • Models cost-effectiveness and budget impact
    • Answers: is it good value?
    • Builds the value story

    Market Access

    • Turns evidence into reimbursement
    • Pricing, HTA and payer strategy
    • Answers: how do we get paid?
    • Delivers the value story

    See market access consulting for the next step after HEOR.

    Who is in the room

    Attendee Breakdown

    A senior, focused audience of the buyers who commission and act on HEOR.

    60%Director / VP and Above
    Director / VP and AboveOther senior roles
    HEOR & Market Access26%
    RWE & Real-World Data22%
    Health Economics & Biostatistics16%
    Clinical & Medical Affairs14%
    Regulatory, Payer & Policy12%
    Research, Academia & Startups10%

    Seniority is confirmed: 150+ attendees, around 60% at Director or VP level and above. The functional mix shown is indicative; confirmed registration splits are shared with sponsors from the live delegate list.

    Why sponsor

    Meet the Teams That Commission HEOR

    Reach the HEOR BuyersMarket access, HEOR and RWE leaders who commission economic evidence, around 60% at Director level and above.
    Pre-Scheduled 1:1 MeetingsName the buyers you want; the Partnering Lounge books the meetings before the doors open.
    Demos and SpeakingShare your methods and case studies with the people who buy them.

    RWE Connect 2026

    Put Your HEOR Practice in Front of the Room

    150+ real-world evidence and market-access buyers, around 60% at Director or VP level and above, over two days in Boston. Request the prospectus and the team replies within one business day.

    • Exhibition space and capability showcases
    • Speaking and panel opportunities
    • Pre-scheduled 1:1 meetings with the buyers you name
    Request the Sponsorship Prospectus
    Three fields. We reply within one business day.

      No public pricing. Enquiry-led, no obligation.

      HEOR Consulting: Common Questions

      What is HEOR?

      Health economics and outcomes research (HEOR) is the discipline that measures the value, costs and outcomes of treatments to inform payer, HTA and clinical decisions.

      What does an HEOR consultancy do?

      HEOR consultancies deliver cost-effectiveness and budget-impact modeling, burden-of-illness studies, payer value dossiers, evidence synthesis and patient-reported outcomes strategy.

      How does HEOR relate to real-world evidence?

      Real-world evidence is a primary input to HEOR. Real-world data feeds the economic models, comparative analyses and value stories that HEOR teams build for payers and HTA bodies.

      What is a cost-effectiveness analysis?

      A method that compares the costs and health outcomes of treatments, often expressed as cost per quality-adjusted life year (the incremental cost-effectiveness ratio, or ICER).

      Which HEOR companies are at RWE Connect 2026?

      Confirmed sponsors to date span data and analytics providers including Truveta, Magnolia, Forian and Arcadia. The agenda features HEOR and market-access sessions with 40+ speakers.

      Can my HEOR company exhibit or sponsor?

      Yes. Request the prospectus for exhibition, speaking and pre-scheduled 1:1 meeting options; pricing is shared on enquiry.

      What is an ICER?

      The incremental cost-effectiveness ratio: the additional cost of a therapy divided by the additional health benefit, often expressed as cost per quality-adjusted life year (QALY).

      What is a QALY?

      A quality-adjusted life year is a measure that combines length of life and quality of life into a single number, used in cost-effectiveness analysis.

      What is the difference between HEOR and market access?

      HEOR generates the economic and outcomes evidence; market access uses that evidence to secure pricing and reimbursement. They work hand in hand.

      When and where is RWE Connect 2026?

      14 to 15 October 2026 at the Hampton Inn by Hilton, Boston Seaport District, Boston, MA.

      How much does HEOR consulting cost?

      It varies with scope, from a single economic model or review to a full HTA program. Cost is best weighed against the value of the access or reimbursement decision it supports.

      When should you engage an HEOR consultant?

      When you have a new evidence need, a regulatory or HTA submission, a capability gap, complex methods, or a need to move quickly with specialist skills.

      Join the Movement. Shape the Future.

      Be part of a community that’s redefining how the world measures healthcare impact.

      Join us at RWE Connect 2026
      where data meets decisions.

      Get Your Complimentary Delegate PassGet Your Complimentary Delegate PassGet Your Complimentary Delegate PassGet Your Complimentary Delegate PassGet Your Complimentary Delegate PassGet Your Complimentary Delegate Pass